DuPont de Nemours (NYSE:DD – Get Free Report) updated its third quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.800-1.900 for the period, compared to the consensus estimate of 1.930. The company issued revenue guidance of $1.8 billion-$1.8 billion, compared to the consensus revenue estimate of $1.9 billion.
DuPont de Nemours Price Performance
NYSE:DD traded up $2.73 on Wednesday, hitting $145.66. The company had a trading volume of 347,517 shares, compared to its average volume of 1,447,706. DuPont de Nemours has a 52 week low of $87.26 and a 52 week high of $157.98. The company has a current ratio of 2.68, a quick ratio of 2.11 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $19.67 billion, a price-to-earnings ratio of -809.13, a PEG ratio of 1.33 and a beta of 1.06. The firm has a 50 day moving average of $139.65 and a two-hundred day moving average of $140.31.
DuPont de Nemours (NYSE:DD – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.76 by $0.12. The business had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.81 billion. DuPont de Nemours had a positive return on equity of 7.15% and a negative net margin of 0.30%.DuPont de Nemours’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.12 earnings per share. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. On average, research analysts anticipate that DuPont de Nemours will post 7.16 earnings per share for the current year.
DuPont de Nemours Cuts Dividend
Analyst Upgrades and Downgrades
DD has been the subject of several analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of DuPont de Nemours in a report on Monday. The Goldman Sachs Group increased their price objective on shares of DuPont de Nemours from $53.00 to $159.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of DuPont de Nemours from $174.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. BMO Capital Markets upped their price target on shares of DuPont de Nemours from $75.30 to $180.00 and gave the company an “outperform” rating in a research report on Tuesday, May 5th. Finally, Zacks Research lowered DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 17th. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $165.33.
Get Our Latest Report on DuPont de Nemours
DuPont de Nemours News Roundup
Here are the key news stories impacting DuPont de Nemours this week:
- Positive Sentiment: Q2 results exceeded expectations: Adjusted earnings per share came in at $1.88 versus the $1.76 consensus estimate, while sales of $1.82 billion topped expectations of $1.81 billion. Revenue increased 4% year over year, supported by healthcare, industrial water and aerospace demand. DuPont Reports Second Quarter 2026 Results
- Positive Sentiment: Full-year outlook raised: DuPont cited stronger pricing, productivity gains and improving end-market demand as reasons for expecting faster second-half growth. The company also plans to repurchase $250 million of shares during the third quarter. DD Q2 Earnings Call Points to Faster Second-Half Growth
- Positive Sentiment: Cash generation was solid: DuPont produced $400 million of operating cash flow and $326 million of transaction-adjusted free cash flow, equal to 127% conversion, supporting capital returns and financial flexibility. DuPont Reports Second Quarter 2026 Results
- Neutral Sentiment: DuPont is exploring potential acquisitions in the water and healthcare markets, which could expand its higher-growth businesses but may introduce execution and valuation risks.
- Neutral Sentiment: New Corian Design distribution arrangements with Hallmark Building Supplies and Parksite should improve regional product availability and support the 2026 Nature in Motion launch, but the near-term financial impact is likely limited. DuPont Strengthens Corian Design Distribution Network
- Neutral Sentiment: DuPont’s FilmTec Fortilife XC220 water-treatment membrane received sustainability-product recognition, reinforcing its industrial water positioning without immediately changing earnings expectations. FilmTec Fortilife XC220 Sustainability Recognition
- Negative Sentiment: Near-term guidance lagged estimates: Third-quarter adjusted EPS guidance of $1.80–$1.90 and revenue guidance of approximately $1.8 billion are below consensus expectations of $1.93 and $1.9 billion, respectively.
Hedge Funds Weigh In On DuPont de Nemours
Large investors have recently modified their holdings of the company. Palisade Asset Management LLC acquired a new position in shares of DuPont de Nemours during the third quarter valued at about $26,000. Imprint Wealth LLC purchased a new stake in shares of DuPont de Nemours in the third quarter worth approximately $27,000. Measured Wealth Private Client Group LLC bought a new position in shares of DuPont de Nemours in the third quarter valued at approximately $30,000. Atlas Capital Advisors Inc. purchased a new position in shares of DuPont de Nemours during the fourth quarter valued at approximately $38,000. Finally, Ameriflex Group Inc. grew its stake in shares of DuPont de Nemours by 5,940.0% in the 4th quarter. Ameriflex Group Inc. now owns 1,208 shares of the basic materials company’s stock worth $49,000 after acquiring an additional 1,188 shares in the last quarter. 73.96% of the stock is currently owned by institutional investors.
About DuPont de Nemours
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
- Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
